Oseltamivir - Latest Advances

Drugs past their expiration date.

Journal: The Medical letter on drugs and therapeutics

Published: January 08, 2026

Identification and characterization of a novel inhibitor of influenza A virus that acts by blocking nucleoprotein oligomerization.

Journal: Antimicrobial agents and chemotherapy

Published: December 19, 2025

Necrotizing Pneumonia in a Vaccinated Child: A Rare Complication of Viral and Bacterial Co-infection.

Journal: Cureus

Published: December 15, 2025

Evaluation of combining the PDX analogue AN-137B with oseltamivir in a mouse model of severe influenza A (H1N1) infection.

Journal: Antiviral therapy

Published: December 09, 2025

Expansion of influenza A(H1N1)pdm09 NA:S247N viruses with reduced susceptibility to oseltamivir, Catalonia, Spain, and in Europe, July to October 2025.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: December 05, 2025

Emerging trends and hotspots in Oseltamivir resistance: insights from a bibliometric investigation.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: December 04, 2025

Tezepelumab in near-fatal asthma requiring VV-ECMO.

Journal: Respiratory medicine case reports

Published: November 27, 2025

Rebalancing viral and immune damage versus repair prevents death from lethal influenza infection.

Journal: Science (New York, N.Y.)

Published: November 20, 2025

Hospital Influenza Outbreak Management in the Post-COVID Era: A Narrative Review of Evolving Practices and Feasibility Considerations.

Journal: Healthcare (Basel, Switzerland)

Published: November 16, 2025

RETRACTION: Lianhua-Qingwen Displays Antiviral and Anti-Inflammatory Activity and Synergistic Effects with Oseltamivir against Influenza B Virus Infection in the Mouse Model.

Journal: Evidence-based complementary and alternative medicine : eCAM

Published: November 08, 2025

Corrigendum to "Characterization and bioevaluation of radioiodinated oseltamivir phosphate for inflammation imaging as a new perspective" [Bioorg. Chem. 165 (2025) 109050].

Journal: Bioorganic chemistry

Published: November 04, 2025

Comprehensive evaluation of therapeutic effectiveness and safety profiles of baloxavir marboxil for managing influenza virus infection in pediatric populations: a systematic review with pooled meta-analytic data.

Journal: Frontiers in pediatrics

Published: October 27, 2025

Filters

Drugs past their expiration date.

Drugs past their expiration date.

Identification and characterization of a novel inhibitor of influenza A virus that acts by blocking nucleoprotein oligomerization.

Identification and characterization of a novel inhibitor of influenza A virus that acts by blocking nucleoprotein oligomerization.

Necrotizing Pneumonia in a Vaccinated Child: A Rare Complication of Viral and Bacterial Co-infection.

Necrotizing Pneumonia in a Vaccinated Child: A Rare Complication of Viral and Bacterial Co-infection.

Evaluation of combining the PDX analogue AN-137B with oseltamivir in a mouse model of severe influenza A (H1N1) infection.

Evaluation of combining the PDX analogue AN-137B with oseltamivir in a mouse model of severe influenza A (H1N1) infection.

Expansion of influenza A(H1N1)pdm09 NA:S247N viruses with reduced susceptibility to oseltamivir, Catalonia, Spain, and in Europe, July to October 2025.

Expansion of influenza A(H1N1)pdm09 NA:S247N viruses with reduced susceptibility to oseltamivir, Catalonia, Spain, and in Europe, July to October 2025.

Emerging trends and hotspots in Oseltamivir resistance: insights from a bibliometric investigation.

Emerging trends and hotspots in Oseltamivir resistance: insights from a bibliometric investigation.

Tezepelumab in near-fatal asthma requiring VV-ECMO.

Tezepelumab in near-fatal asthma requiring VV-ECMO.

Rebalancing viral and immune damage versus repair prevents death from lethal influenza infection.

Rebalancing viral and immune damage versus repair prevents death from lethal influenza infection.

Hospital Influenza Outbreak Management in the Post-COVID Era: A Narrative Review of Evolving Practices and Feasibility Considerations.

Hospital Influenza Outbreak Management in the Post-COVID Era: A Narrative Review of Evolving Practices and Feasibility Considerations.

RETRACTION: Lianhua-Qingwen Displays Antiviral and Anti-Inflammatory Activity and Synergistic Effects with Oseltamivir against Influenza B Virus Infection in the Mouse Model.

RETRACTION: Lianhua-Qingwen Displays Antiviral and Anti-Inflammatory Activity and Synergistic Effects with Oseltamivir against Influenza B Virus Infection in the Mouse Model.

Corrigendum to "Characterization and bioevaluation of radioiodinated oseltamivir phosphate for inflammation imaging as a new perspective" [Bioorg. Chem. 165 (2025) 109050].

Corrigendum to "Characterization and bioevaluation of radioiodinated oseltamivir phosphate for inflammation imaging as a new perspective" [Bioorg. Chem. 165 (2025) 109050].

Comprehensive evaluation of therapeutic effectiveness and safety profiles of baloxavir marboxil for managing influenza virus infection in pediatric populations: a systematic review with pooled meta-analytic data.

Comprehensive evaluation of therapeutic effectiveness and safety profiles of baloxavir marboxil for managing influenza virus infection in pediatric populations: a systematic review with pooled meta-analytic data.